CancerIQ Expands Diagnostic Network with Addition of geneType™ PRS Test from Rhythm Biosciences

Now available for clinical ordering across CancerIQ's network of 60+ health systems CHICAGO, June 2, 2026 /PRNewswire/ -- CancerIQ today announced that the geneType™ Cancer Risk Assessment from Rhythm Biosciences is now available on the CancerIQ platform, expanding the tools providers can...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.